The impact of Part D on manufacturers

Lipowski, Earlene
January 2007
Drug Topics;1/8/2007, Vol. 151 Issue 1, p30
Trade Publication
The article discusses the benefits and impacts of Medicare Part D plan on Medicare beneficiaries and pharmaceutical manufacturers in the U.S. It mentioned that the benefit is seen to increase access to medication among, the government programs runs, risk of concentrating purchase power by lowering prices and decreases profits of the manufacturers. Part D will shift spending from Medicaid and the private sector to make Medicare the largest prescription drug purchaser in the country. Even though, there is hostility toward the perceived gains of the manufacturers from Part D, but many patients seems to be satisfied with the program.


Related Articles

  • Pharmacy gets congressional support on Medicaid issue. Frederick, Jim // Drug Store News;3/19/2007, Vol. 29 Issue 4, p3 

    The article reports that retail pharmacy leaders gets congressional support to preserve a fair reimbursement system due to a proposed changes in the Medicaid prescription in Washington, D.C. Pharmacy leaders fear that the change will severely reduce payments, undermine pharmacy profitability,...

  • A Comparison of Medicaid Reimbursement for Nondefinitive Pediatric Dental Treatment in the Emergency Room Versus Periodic Preventive Care. Pettinato, Erika S.; Webb, Michael D.; Seale, N. Sue // Pediatric Dentistry;Nov/Dec2000, Vol. 22 Issue 6, p463 

    Purpose: This study compared the expenditure by the state Medicaid program for episodic, nondefinitive care provided through the emergency room (ER) of a children's hospital with the cost to Medicaid of covering that same child with the recommended preventive service calculated on the fee...

  • Part D donut hole to be 'brutal'.  // Drug Topics;4/17/2006, Vol. 150 Issue 8, p10 

    The article reports on the impending out-of-pocket medication expenses to be shouldered by Medicare Part D donut hole enrollees this summer of 2006 in the U.S. In a speech before the Medicare Part D Executive Roundtable conference cosponsored by "Drug Topics," and the Global Knowledge Congress,...

  • EQUITY AND MEDICAID. Stuart, Bruce // Journal of Human Resources;Spring72, Vol. 7 Issue 2, p162 

    ABSTRACT This paper is concerned with the differential impact of the Medicaid program on state incomes in 1967-68. Benefits and costs of the program are calculated for each state and the results are evaluated in terms of the perceived original intent of the program planners. It was found that...

  • Restoring Fiscal Integrity To Medicaid Financing? Coughlin, Teresa A.; Zuckerman, Stephen; McFeeters, Joshua // Health Affairs;Sep/Oct2007, Vol. 26 Issue 5, p1469 

    Using survey data, we examined Medicaid supplemental payments (SPs), including disproportionate-share hospital (DSH) and upper payment limit (UPL) payments in 2005 and changes in these payments between 2001 and 2005. We found that states increased their use of general funds in financing of DSH...

  • Walgreens leads fight as Del. sharpens Medicaid axe. Frederick, Jim // Drug Store News;6/29/2009, Vol. 31 Issue 7, p84 

    The article focuses on the stand of Walgreens to oppose the plan of Delaware Medicaid administrators to reduce pharmacy reimbursements starting July 1, 2009. It outlines the warning of Walgreens to withdraw from serving Medicaid patients unless health policy-makers will remove their plan to...

  • Skilled Nursing Facility Charges, by Type of Service: CYs 1990 and 1992.  // Health Care Financing Review;Summer94 Supplement, Vol. 15, p66 

    The article provides information on Medicare-covered skilled nursing facility (SNF) charges in the United States in 1990 and 1992. The ratio of ancillary charges to covered charges increased from 41.5% in 1990 to 47.2% in 1992. On the other hand, the ratio of accommodation charges to covered...

  • Special Needs Plans And The Coordination Of Benefits And Services For Dual Eligibles. Grabowski, David C. // Health Affairs;Jan/Feb2009, Vol. 28 Issue 1, p136 

    Special Needs Plans (SNPs) are a new type of Medicare Advantage (MA) plan with the potential to coordinate Medicare and Medicaid benefits and services for dually eligible beneficiaries. However, experience to date suggests that SNPs have not greatly expanded the number of people enrolled in...

  • Medicare Part D: maintaining the spending status quo?  // PharmacoEconomics & Outcomes News;7/11/2009, Issue 582, p7 

    The article discusses research on the effect of Medicare Part D enrolment on prescription drug spending in the U.S. It references a study by Y. Zhang et al., published in the July 2, 2009 issue of "New England Journal of Medicine" (NEJM). The researchers observed that while spending on...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics